LakeShore Biopharma (YS) Revenue & Revenue Breakdown
LakeShore Biopharma Revenue Highlights
Latest Revenue (Y)
$687.20M
Latest Revenue (Q)
$164.98M
LakeShore Biopharma Revenue by Period
LakeShore Biopharma Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-03-31 | $687.20M | 36.63% |
| 2022-03-31 | $502.95M | 95.69% |
| 2021-03-31 | $257.02M | - |
LakeShore Biopharma generated $687.20M in revenue during NA 2023, up 36.63% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
LakeShore Biopharma Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $164.98M | 70.40% |
| 2023-09-30 | $96.82M | -45.08% |
| 2023-06-30 | $176.27M | -2.96% |
| 2022-12-31 | $181.65M | -6.39% |
| 2022-09-30 | $194.06M | -5.56% |
| 2022-06-30 | $205.48M | - |
LakeShore Biopharma generated $164.98M in revenue during Q3 2024, up 70.40% compared to the previous quarter, and up 80.29% compared to the same period a year ago.
LakeShore Biopharma Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| YS | LakeShore Biopharma | $687.20M | $164.98M |
| BDRX | Biodexa Pharmaceuticals | $381.00K | $41.50K |
| SONN | Sonnet BioTherapeutics | $147.81K | - |
| VRAX | Virax Biolabs Group | $8.56K | $76.50K |
| CNSP | CNS Pharmaceuticals | - | - |
| ZURA | Zura Bio | - | - |
| REVB | Revelation Biosciences | - | - |
| ZVSA | ZyVersa Therapeutics | - | - |
| IMMX | Immix Biopharma | - | - |
| ALLR | Allarity Therapeutics | - | - |
| VIRI | Virios Therapeutics | - | - |
| EFTR | eFFECTOR Therapeutics | - | - |
| QNRX | Quoin Pharmaceuticals | - | - |
| CDIO | Cardio Diagnostics | - | $7.87K |
YS Revenue FAQ
What is LakeShore Biopharma’s yearly revenue?
LakeShore Biopharma's yearly revenue for 2023 was $687.2M, representing an increase of 36.63% compared to 2022. The company's yearly revenue for 2022 was $502.95M, representing an increase of 95.69% compared to 2021. YS's yearly revenue for 2021 was $257.02M, representing an increase of 0% compared to 2020.
What is LakeShore Biopharma’s quarterly revenue?
LakeShore Biopharma's quarterly revenue for Q3 2024 was $164.98M, a 70.40% increase from the previous quarter (Q2 2024), and a -14.99% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q2 2024 was $96.82M, a -45.08% decrease from the previous quarter (Q1 2024), and a -52.88% decrease year-over-year (Q1 2023). YS's quarterly revenue for Q1 2024 was $176.27M, a -2.96% decrease from the previous quarter (Q3 2023).
What is LakeShore Biopharma’s revenue growth rate?
LakeShore Biopharma's revenue growth rate for the last 3 years (2021-2023) was 167.38%